Last updated on June 2019

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors


Brief description of study

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.

Clinical Study Identifier: NCT03314935

Find a site near you

Start Over